Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 14cyclopia sequence 7Neoplasms 7Prostatic Neoplasms 6Polycystic Ovary Syndrome 5Fatigue 5Lung Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Pain 3Obesity 3Neoplasm Metastasis 3Vomiting 2Urinary Bladder Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Neoplasms, Plasma Cell 2Nausea 2Multiple Myeloma 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Insulin Resistance 2Infertility 2Hyperandrogenism 2Depression 2Burkitt Lymphoma 2Weight Loss 1Vitamin D Deficiency 1Tobacco Use Cessation 1

Interventions

Surveys and Questionnaires 7Tobacco Use Cessation Devices 4Varenicline 2Videotape Recording 1Tomography, X-Ray Computed 1Tobacco Products 1Sugars 1Interviews as Topic 1Focus Groups 1Counseling 1Carbon Monoxide 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Tobacco Use Cessation × Sugars × Clear all
NCT02162849 2026-02-09

Reward Sensitivity and Pharmacotherapy for Smoking Cessation

M.D. Anderson Cancer Center

Phase 4 Active not recruiting
204 enrolled

Smoking Cessation, Tobacco Use Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡